🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of Tylenol, asserting the companies withheld potential risks that the medication posed to pediatric brain development.

The court filing comes a month after Former President Trump publicized an unproven link between consuming Tylenol - also known as acetaminophen - while pregnant and autism spectrum disorder in young ones.

The attorney general is taking legal action against J&J, which once produced the drug, the only pain reliever suggested for expectant mothers, and Kenvue, which currently produces it.

In a statement, he stated they "deceived the public by gaining financially from suffering and promoting medication without regard for the dangers."

Kenvue asserts there is insufficient reliable data tying acetaminophen to autism.

"These companies misled for generations, deliberately risking countless individuals to boost earnings," the attorney general, from the Republican party, declared.

The manufacturer said in a statement that it was "very worried by the perpetuation of misinformation on the security of acetaminophen and the possible consequences that could have on the welfare of US mothers and children."

On its online platform, Kenvue also mentioned it had "consistently assessed the pertinent research and there is no credible data that demonstrates a proven link between using paracetamol and autism spectrum disorder."

Organizations representing physicians and medical practitioners agree.

ACOG has said acetaminophen - the key substance in Tylenol - is a restricted selection for women during pregnancy to address pain and fever, which can pose significant medical dangers if left untreated.

"In over twenty years of research on the utilization of acetaminophen in gestation, no reliable research has successfully concluded that the use of paracetamol in any stage of pregnancy results in neurodevelopmental disorders in young ones," the association said.

The lawsuit references current declarations from the former administration in claiming the drug is allegedly unsafe.

Last month, Trump generated worry from medical authorities when he instructed pregnant women to "resist strongly" not to consume Tylenol when ill.

Federal regulators then released a statement that doctors should think about restricting the usage of Tylenol, while also stating that "a direct connection" between the drug and autism in children has remains unverified.

The Health Department head RFK Jr, who oversees the FDA, had vowed in spring to conduct "extensive scientific investigation" that would determine the cause of autism spectrum disorder in a limited time.

But specialists warned that finding a single cause of autism - believed by scientists to be the outcome of a complicated interplay of genetic and external influences - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and disability that affects how individuals perceive and interact with the surroundings, and is diagnosed using medical professional evaluations.

In his legal document, Paxton - a Trump ally who is running for US Senate - asserts the manufacturer and J&J "willfully ignored and sought to suppress the science" around paracetamol and autism spectrum disorder.

This legal action seeks to make the firms "remove any marketing or advertising" that states acetaminophen is reliable for women during pregnancy.

This legal action echoes the grievances of a assembly of parents of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in two years ago.

Judicial authorities rejected the legal action, saying investigations from the family's specialists was inconclusive.